The Role of Craving in Alcohol Use, Dependence, and Treatment

Authors

  • Barbara A. Flannery,

    Corresponding author
    1. Center for the Study of Addictions (BAF), University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Neuropharmacology (AJR), The Scripps Research Institute, La Jolla, California; Yale University and VA Connecticut Healthcare System (NLC), Newington, Connecticut; VA Medical Center (RMS), Providence, Rhode Island; Medical University of South Carolina (RFA), Charleston, South Carolina; and Brown University Center for Alcohol and Addiction Studies (DJR), Providence, Rhode Island.
    Search for more papers by this author
  • Amanda J. Roberts,

    1. Center for the Study of Addictions (BAF), University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Neuropharmacology (AJR), The Scripps Research Institute, La Jolla, California; Yale University and VA Connecticut Healthcare System (NLC), Newington, Connecticut; VA Medical Center (RMS), Providence, Rhode Island; Medical University of South Carolina (RFA), Charleston, South Carolina; and Brown University Center for Alcohol and Addiction Studies (DJR), Providence, Rhode Island.
    Search for more papers by this author
  • Ned Cooney,

    1. Center for the Study of Addictions (BAF), University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Neuropharmacology (AJR), The Scripps Research Institute, La Jolla, California; Yale University and VA Connecticut Healthcare System (NLC), Newington, Connecticut; VA Medical Center (RMS), Providence, Rhode Island; Medical University of South Carolina (RFA), Charleston, South Carolina; and Brown University Center for Alcohol and Addiction Studies (DJR), Providence, Rhode Island.
    Search for more papers by this author
  • Robert M. Swift,

    1. Center for the Study of Addictions (BAF), University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Neuropharmacology (AJR), The Scripps Research Institute, La Jolla, California; Yale University and VA Connecticut Healthcare System (NLC), Newington, Connecticut; VA Medical Center (RMS), Providence, Rhode Island; Medical University of South Carolina (RFA), Charleston, South Carolina; and Brown University Center for Alcohol and Addiction Studies (DJR), Providence, Rhode Island.
    Search for more papers by this author
  • Raymond F. Anton,

    1. Center for the Study of Addictions (BAF), University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Neuropharmacology (AJR), The Scripps Research Institute, La Jolla, California; Yale University and VA Connecticut Healthcare System (NLC), Newington, Connecticut; VA Medical Center (RMS), Providence, Rhode Island; Medical University of South Carolina (RFA), Charleston, South Carolina; and Brown University Center for Alcohol and Addiction Studies (DJR), Providence, Rhode Island.
    Search for more papers by this author
  • Damaris J. Rohsenow

    1. Center for the Study of Addictions (BAF), University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Neuropharmacology (AJR), The Scripps Research Institute, La Jolla, California; Yale University and VA Connecticut Healthcare System (NLC), Newington, Connecticut; VA Medical Center (RMS), Providence, Rhode Island; Medical University of South Carolina (RFA), Charleston, South Carolina; and Brown University Center for Alcohol and Addiction Studies (DJR), Providence, Rhode Island.
    Search for more papers by this author

  • Research presented in this symposium was supported by Grants AA-07517, AA-06420, AA-08459, AA-11197, AA-09568, AA-11783, and AA-097850 from the NIAAA.

Reprint requests: Barbara A Flannery, PhD, Center for the Study of Addictions, University of Pennsylvania, 3900 Chestnut Street, Philadelphia, PA 19104; Fax 215-386-6770; E-mail: flannery_b@mail.trc.upenn.edu

Abstract

This article represents the proceedings of a symposium at the 2000 RSA Meeting in Denver, Colorado. The organizer and chair was Barbara A. Flannery, and the co-chairs were Barbara A. Flannery and Helen Pettinati. The presentations were (1) Animal models of alcohol craving and relapse, by Amanda Roberts; (2) Real-time field assessment of alcohol craving, by Ned Cooney; (3) Medications and alcohol craving, by Robert Swift; (4) The assessment of craving: Insights from the clinic and clinical laboratory studies, by Raymond Anton; (5) A comparison of three alcohol craving questionnaires, by Barbara Flannery; (6) and Assessing posttreatment urge to drink, by Damaris Rohsenow.

Ancillary